Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002000579 | SCV002269156 | uncertain significance | Lymphoproliferative syndrome 1 | 2022-08-23 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 521 of the ITK protein (p.Pro521Leu). This variant is present in population databases (rs759932471, gnomAD 0.007%). This missense change has been observed in individual(s) with autoimmune lymphoproliferative syndrome and/or primary immunodeficiency (PMID: 32628964, 32888943). ClinVar contains an entry for this variant (Variation ID: 1481575). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ITK protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Nemer Genomics and Translation Biomedicine Lab, |
RCV002251774 | SCV002522162 | uncertain significance | Vitiligo-associated multiple autoimmune disease susceptibility 1 | no assertion criteria provided | clinical testing |